Home-Based Tele-Exercise vs. Hospital-Based Exercise Programs in Patients With Prediabetes
Effectiveness of Home-Based Tele-Exercise vs Center-Based Exercise Programs in Patients With Prediabetes: A Comparative Study
1 other identifier
interventional
42
1 country
1
Brief Summary
This study aims to compare the effects of tele-exercise(TELE) and hospital-based exercise(HBE) on functional capacity (maximum oxygen consumption), glycemic control, quality of life and sleep quality in individuals with prediabetes. Aerobic exercise will be performed 5 days a week for 30 minutes with moderate intensity continuous walking for a total of 3 weeks.While the HBE group will the exercise program under supervision in hospital,the TELE group wil perform the exercise program at home/outdoors using Polar H9 heart rate monitor. The control group (CON) will perform the exercise program at home/outdoors without any monitoring or follow up.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Apr 2025
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
March 24, 2025
CompletedFirst Posted
Study publicly available on registry
March 26, 2025
CompletedStudy Start
First participant enrolled
April 1, 2025
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 15, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
December 15, 2025
CompletedApril 9, 2026
April 1, 2026
9 months
March 24, 2025
April 8, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
2-hour postprandial glucose
Plasma glucose level is measured 2 hours after the person drinks 75 g of glucose solution.(oral glucose tolerence test). Below 140 mg/dL normal, 140-199 mg/dL prediabetes, 200 mg/dL or higher indicates diabetes.
From enrollment day to the end of the exercise program at 3 weeks.
Maximum oxygen consumption (VO2max)
It is the highest amount of oxygen that patients can consume during incremental aerobic exercise and is considered the best indicator of exercise capacity.
From enrollment day to the end of the exercise program at 3 weeks
Glucose area under the curve (AUC)
It is the value obtained by calculating the area under the curve after 75 g of Oral Glucose Tolerance Test. PG=Plasma glucose Formule is; ( PG(0) +PG(30)×2+PG(60)×3+PG(120)×2 )/4 Glucose excursion, rather than PG levels at a point, is considered to provide more information about glucose tolerance. The glucose area under the curve (AUC), which is an index of whole glucose excursion after glucose loading, has been widely used for calculating the glycemic index and for evaluating the efficacy of treatment for postprandial hyperglycemia
From enrollment day to the end of the exercise program at 3 weeks
Secondary Outcomes (9)
Fasting glucose
From enrollment day to the end of the exercise program at 3 weeks.
Fasting insuline
From enrollment day to the end of the exercise program at 3 weeks.
36-Item Short Form Survey
From enrollment day to the end of the exercise program at 3 weeks
Pittsburgh sleep quality index
From enrollment day to the end of the exercise program at 3 weeks
Hemoglobin A1c (HbA1c)
From enrollment day to the end of the exercise program at 3 weeks
- +4 more secondary outcomes
Study Arms (3)
Hospital-based exercise group
ACTIVE COMPARATORParticipants in the hospital-based exercise group will perform aerobic exercises under the supervision of a nurse/research doctor five days a week for three weeks in the cardiopulmonary rehabilitation unit.Aerobic exercise will include 30-minute treadmill walking at %55-75 of the maximal heart rate.At the end of three weeks the program will be terminated and a follow-up evaluation will be conducted.
Tele-exercise group
EXPERIMENTALParticipants in the tele-exercise group will be instructed to walk continuously at moderate intensity (between 55-75% of the maximum heart rate) at home or outdoors five days a week, 30 minutes each, for three weeks usuing the heart rate monitor( Polar H9).The heart rates will be monitored by providing remote access to the data of the polar. Participants will be trained in the CPET performed before treatment to walk in a way that will keep their heart rates within the desired range.During the program the researcher will call them twice a week.Phone calls will include symptom inquiry and encouraging feedback regarding exercise parameters recorded on the Polar H9. At the end of three weeks the program will be terminated and a follow-up evaluation will be conducted.
Control group
NO INTERVENTIONPatients will be advised to exercise at a moderate intensity (between 55-75% of maximum heart rate) five days a week, 30 minutes each, for 3 weeks, at home or outdoors as recommended for prediabetes in the routine.Participants in this group will not be monitored with Polar or any device.They will be asked to take note of the exercise they have done. Participants will be trained in the CPET performed before treatment to walk in a way to maintain their heart rate in the desired range. At the end of three weeks the program will be terminated and a follow-up evaluation will be conducted.
Interventions
Aerobic exercise at home/outdoors 30 minutes each session,five days a week for three weeks using a Polar H9 heart rate monitor.
The aerobic exercise ,30 minutes each session,five days a week for three weeks at cardiopulmonary rehabilitation unit under supervision.
Calls twice a week that include symptom inquiries and encouraging feedback on exercise
Eligibility Criteria
You may qualify if:
- Accepting to participate in the study
- ≥18 and \<80 years of age
- With oral glucose tolerance test (after 75 g oral glucose) 2nd hour glucose value: 140-199 mg/dl or fasting blood glucose : 100-125 mg/dl and diagnosed as prediabetes by an endocrinologist
You may not qualify if:
- High physical activity: Performing ≥150 minutes of moderate-intensity exercise per week
- Using insulin or oral antidiabetics
- Presence of cardiac and physical conditions that would prevent aerobic exercise
- Presence of neurological disease with significant sensorimotor deficit
- Presence of active malignancy
- Neuropsychiatric disease or condition that may prevent cooperation
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Gazi Universitylead
Study Sites (1)
Gazi University Hospital,Department of Physical Medicine and Rehabilitation
Ankara, Ankara, 06560, Turkey (Türkiye)
Related Publications (4)
Sakaguchi K, Takeda K, Maeda M, Ogawa W, Sato T, Okada S, Ohnishi Y, Nakajima H, Kashiwagi A. Glucose area under the curve during oral glucose tolerance test as an index of glucose intolerance. Diabetol Int. 2015 May 14;7(1):53-58. doi: 10.1007/s13340-015-0212-4. eCollection 2016 Mar.
PMID: 30603243RESULTDuruturk N. Telerehabilitation intervention for type 2 diabetes. World J Diabetes. 2020 Jun 15;11(6):218-226. doi: 10.4239/wjd.v11.i6.218.
PMID: 32547696RESULTDuruturk N, Ozkoslu MA. Effect of tele-rehabilitation on glucose control, exercise capacity, physical fitness, muscle strength and psychosocial status in patients with type 2 diabetes: A double blind randomized controlled trial. Prim Care Diabetes. 2019 Dec;13(6):542-548. doi: 10.1016/j.pcd.2019.03.007. Epub 2019 Apr 20.
PMID: 31014938RESULTBlioumpa C, Karanasiou E, Antoniou V, Batalik L, Kalatzis K, Lanaras L, Pepera G. Efficacy of supervised home-based, real time, videoconferencing telerehabilitation in patients with type 2 diabetes: a single-blind randomized controlled trial. Eur J Phys Rehabil Med. 2023 Oct;59(5):628-639. doi: 10.23736/S1973-9087.23.07855-3. Epub 2023 Jun 23.
PMID: 37350165RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Çise C Güngör, MD
Gazi University Faculty of Medicine
- PRINCIPAL INVESTIGATOR
Nesrin Ü Demirsoy, MD
Gazi University Faculty of Medicine
- PRINCIPAL INVESTIGATOR
Levent Karataş, MD
Gazi University Faculty of Medicine
- PRINCIPAL INVESTIGATOR
Muhittin M Yalçın, MD
Gazi University Faculty of Medicine
- PRINCIPAL INVESTIGATOR
Levent A Güngör, MD
Gazi University Faculty of Medicine
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- OUTCOMES ASSESSOR
- Purpose
- HEALTH SERVICES RESEARCH
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- PM&R Specialist M.D
Study Record Dates
First Submitted
March 24, 2025
First Posted
March 26, 2025
Study Start
April 1, 2025
Primary Completion
December 15, 2025
Study Completion
December 15, 2025
Last Updated
April 9, 2026
Record last verified: 2026-04
Data Sharing
- IPD Sharing
- Will not share